Neuromodulation of the Autonomic Nervous System in Athletes

Launched by BAKULEV SCIENTIFIC CENTER OF CARDIOVASCULAR SURGERY · Feb 26, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating how a specific treatment called transcutaneous vagus nerve stimulation (tVNS) can help athletes recover faster after intense physical activity. The researchers want to see if this treatment can improve heart rate recovery, lower levels of lactic acid in the blood (which can cause fatigue), and reduce pain and feelings of being overtrained. This study is particularly focused on athletes aged 15 to 35 who participate in certain sports, like swimming, athletics, and dance sports, and who meet specific performance criteria.

If you are a professional athlete in this age range and are interested in participating, you would need to provide consent and meet the inclusion criteria. However, some heart conditions or recent use of certain medications could exclude you from the study. Participants can expect to receive the tVNS treatment and be monitored for its effects on their recovery and overall performance. This trial is currently recruiting, so it's a good opportunity for eligible athletes looking to enhance their recovery process.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Professional athletes over the age of 15 and under the age of 35;
• • Cyclic sports (swimming, modern pentathlon, athletics, triathlon);
• • Difficult coordination sports (dance sports, rhythmic gymnastics);
• • Sports category: no lower than candidate for master of sports;
• • Voluntary informed consent.
• Exclusion Criteria:
• • Atypical and unrelated to physical exertion changes on the ECG (T wave inversion, st-segment depression, pathological Q waves, signs of left atrial enlargement, signs of right ventricular hypertrophy, ventricular pre-excitation, complete right or left bundle branch block, prolonged or shortened Q-T interval, Brugada-like early repolarization);
• • Heart rhythm and conduction disorders (frequent ventricular and supraventricular extrasystoles, first-degree atrioventricular block (P-Q \> 0.21 s, not shortened during hyperventilation or physical exertion), second or third degree);
• • Expressed sinus bradycardia with resting heart rate \< 40 bpm;
• • Taking glucocorticosteroids in the last 1 month;
• • Taking any antiarrhythmic drugs, including beta-blockers.